For the quarter ending 2025-12-27, HAE made $338,967,000 in revenue. $44,740,000 in net income. Net profit margin of 13.20%.
| Income Statement | 2025-12-27 | 2025-09-27 | 2025-06-28 | 2025-03-29 |
|---|---|---|---|---|
| Net revenues | 338,967,000 | 327,315,000 | 321,394,000 | 330,599,000 |
| Cost of goods sold | 136,581,000 | 132,571,000 | 129,150,000 | 137,549,000 |
| Gross profit | 202,386,000 | 194,744,000 | 192,244,000 | 193,050,000 |
| Research and development | 14,187,000 | 14,872,000 | 16,261,000 | 15,914,000 |
| Impairment of intangible assets | - | - | - | 597,750 |
| Remeasurement of contingent consideration | - | - | - | -5,755,500 |
| Selling, general and administrative | 109,154,000 | 101,615,000 | 110,719,000 | 115,136,000 |
| Amortization of acquired assets | 10,933,000 | 11,182,000 | 11,392,000 | 11,296,000 |
| Impairment of intangible assets | 716,000 | 8,584,000 | - | - |
| Total operating expenses | 134,990,000 | 136,253,000 | 138,372,000 | 121,715,000 |
| Operating income | 67,396,000 | 58,491,000 | 53,872,000 | 71,335,000 |
| Interest and other expense, net | -7,421,000 | -7,206,000 | -8,703,000 | -598,000 |
| Income before provision for income taxes | 59,975,000 | 51,285,000 | 45,169,000 | 70,737,000 |
| Provision for income taxes | 15,235,000 | 12,601,000 | 11,138,000 | 12,779,000 |
| Net income | 44,740,000 | 38,684,000 | 34,031,000 | 57,981,000 |
| Basic (in shares) | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 |
| Basic income (loss) per share (in dollars per share) | 0.96 | 0.81 | 0.71 | 1.17 |
| Diluted (in shares) | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 |
| Diluted income (loss) per share (in dollars per share) | 0.95 | 0.81 | 0.7 | 1.17 |
HAEMONETICS CORP (HAE)
HAEMONETICS CORP (HAE)